Arca
Skip to content
Tools
Tools

Acute kidney injury

Drug research and approvals for acute kidney injury: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 205 studies of acute kidney injury are recruiting on ClinicalTrials.gov, and Health Canada has authorized 3 drug trials for it since 2013.

  • Recruiting worldwide: 205
  • Trials authorized in Canada: 3
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 205 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 3 12 of 17

Phase 2 12 of 27

Phase 1 or earlier 12 of 13

How its trials ended

1,382 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 244 whose ending is known, 27% met their primary endpoint, 18% missed it and 55% stopped early.

  • Completed, result not reported58542%
  • Ongoing31123%
  • Status unknown24218%
  • Stopped: other or unclear806%
  • Met its primary endpoint655%
  • Missed its primary endpoint453%
  • Stopped: enrollment or feasibility322%
  • Stopped: lack of efficacy101%
  • Stopped: sponsor or business decision6<1%
  • Stopped: funding6<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Oct 1, 2025A phase IIa, randomised, double-blind, placebo-controlled, multicentre study to assess the efficacy, safety, and tolerability of AZD4144 in participants with…AZD4144AstraZeneca PharmaceuticalsOngoing
Feb 12, 2025The prevention of nephrotoxin-induced acute kidney injury using cilastatin (PONTIAK): a phase 2b vanguard design, randomized, double-blind, placebo-controlled…CilastatinGovernors of The University of CalgaryOngoing
Sep 4, 2024A phase II, randomized, double-blind, placebo-controlled study of the efficacy and safety of GDC-8264 in preventing cardiac surgery-associated acute kidney…RO7288817 (GDC-8264)RocheClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.